Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma

por William, Doreen, Walther, Madlin, Schneider, Björn, Linnebacher, Michael, Classen, Carl Friedrich
Publicado 2018